Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hemant Surgical IndustriesBOM:543916 -0.87%80 Gross Margin % is 20.97% as of Mar. 2026, which is 12% below its 10-year median of 23.82. GuruFocus rates BOM:543916 with a GF Score™ of 80/100 and a GF Value™ of ₹332.62 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Hemant Surgical Industries ranks worse than 87.95% on this metric.
BOM:543916's Gross Margin % is ranked worse than 87.95% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs BOM:543916: 22.97
Hemant Surgical Industries had a gross margin of 20.97% for the quarter that ended in Mar. 2026 => Competition eroding margins
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Hemant Surgical Industries had a gross margin of 20.97% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Hemant Surgical Industries Gross Margin % Related Terms
Hemant Surgical Industries Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543916 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Hemant Surgical Industries's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemant Surgical Industries Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hemant Surgical Industries's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Hemant Surgical Industries's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Hemant Surgical Industries (BOM:543916) has a Gross Margin % of 20.97% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Hemant Surgical Industries and its competitors. This is 12% below median its historical median of 23.82. Over the past decade, Hemant Surgical Industries' Gross Margin % has ranged from 17.43 to 29.01. According to the industry distribution chart, Hemant Surgical Industries ranks #708 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 88%.
Is Hemant Surgical Industries' Gross Margin % too high?
Hemant Surgical Industries' current Gross Margin % of 20.97% is 12% below median its 10-year median of 23.82. Over the past 10 years, this metric has ranged from a low of 17.43 to a high of 29.01. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Hemant Surgical Industries' value of 20.97% is 59.7% below this industry median. Based on the distribution chart, Hemant Surgical Industries ranks #708 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Hemant Surgical Industries has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hemant Surgical Industries' Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hemant Surgical Industries ranks #708 out of 805 companies for Gross Margin %. This places Hemant Surgical Industries in the lower half of its industry. The industry median Gross Margin % is 52.07. Hemant Surgical Industries' value of 20.97% is 59.7% below this benchmark. Historically, Hemant Surgical Industries' own Gross Margin % has ranged from 17.43 to 29.01 over the past decade. While the company's 10-year median is 23.82 vs. the industry median of 52.07, Hemant Surgical Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hemant Surgical Industries's current Gross Margin % of 20.97% is 59.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Hemant Surgical Industries and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemant Surgical Industries's current Gross Margin % is 20.97%, which is 12% below median its own 10-year median of 23.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemant Surgical Industries stock overvalued right now?
Based on GuruFocus' analysis, Hemant Surgical Industries (BOM:543916) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹332.62, compared to a current price of ₹380.90 — trading 14.5% above its estimated fair value. The current Gross Margin % is 20.97%, which is 12% below median its 10-year median of 23.82 and 59.7% below the Medical Devices & Instruments industry median of 52.07. Hemant Surgical Industries' overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Hemant Surgical Industries (BOM:543916), the current Gross Margin % is 20.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hemant Surgical Industries (BOM:543916) Overvalued in 2026?
Based on GuruFocus' analysis, Hemant Surgical Industries stock appears to be overvalued.
The current stock price of ₹380.90 is trading 14.5% above its estimated GF Value™ of ₹332.62.
GuruFocus considers Hemant Surgical Industries to be Modestly Overvalued.
Key valuation signals for BOM:543916:
Gross Margin %: 20.97% (12% below median its 10-year median of 23.82)
GF Value™: ₹332.62 vs. price of ₹380.90 (14.5% above fair value)
Industry Position: 59.7% below the Medical Devices & Instruments median (#708 of 805)
No single metric tells the full story. See the BOM:543916 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease, (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.
80GF Score
Get the complete analysis for BOM:543916
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543916 has been successfully added to your 
